- Home
- ATXS vs OIS Comparison
ATXS vs OIS Comparison
Compare ATXS & OIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- OIS
- Stock Information
- Founded
- ATXS 2008
- OIS 1995
- Country
- ATXS United States
- OIS United States
- Employees
- ATXS N/A
- OIS N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- OIS Metal Fabrications
- Sector
- ATXS Health Care
- OIS Industrials
- Exchange
- ATXS Nasdaq
- OIS Nasdaq
- Market Cap
- ATXS 424.4M
- OIS 375.7M
- IPO Year
- ATXS 2015
- OIS 2001
- Fundamental
- Price
- ATXS $7.52
- OIS $6.29
- Analyst Decision
- ATXS Buy
- OIS Buy
- Analyst Count
- ATXS 6
- OIS 2
- Target Price
- ATXS $33.00
- OIS $7.25
- AVG Volume (30 Days)
- ATXS 436.6K
- OIS 485.1K
- Earning Date
- ATXS 11-12-2025
- OIS 10-29-2025
- Dividend Yield
- ATXS N/A
- OIS N/A
- EPS Growth
- ATXS N/A
- OIS N/A
- EPS
- ATXS N/A
- OIS 0.11
- Revenue
- ATXS N/A
- OIS $664,287,000.00
- Revenue This Year
- ATXS N/A
- OIS N/A
- Revenue Next Year
- ATXS N/A
- OIS $5.23
- P/E Ratio
- ATXS N/A
- OIS $58.04
- Revenue Growth
- ATXS N/A
- OIS N/A
- 52 Week Low
- ATXS $3.56
- OIS $3.08
- 52 Week High
- ATXS $12.52
- OIS $6.42
- Technical
- Relative Strength Index (RSI)
- ATXS 55.75
- OIS 64.53
- Support Level
- ATXS $6.95
- OIS $5.94
- Resistance Level
- ATXS $7.48
- OIS $6.42
- Average True Range (ATR)
- ATXS 0.42
- OIS 0.23
- MACD
- ATXS -0.01
- OIS 0.02
- Stochastic Oscillator
- ATXS 65.35
- OIS 84.15
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About OIS Oil States International Inc.
Oil States International Inc is a provider of manufactured products and services to the energy, industrial and military sectors. Manufactured products include engineered capital equipment as well as products consumed in the drilling, well construction and production of oil and natural gas. The company sells its products and services to national oil and natural gas companies, oil and natural gas companies, onshore and offshore drilling companies and other oilfield services, defense and industrial companies. The company operates through three business segments, Offshore Manufactured Products, Completion and Production Services and Downhole Technologies. It gains maximum revenue from Offshore Manufactured Products.